Vessel destruction by tumor-targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularity.
about
Spontaneous regression of tumour and the role of microbial infection--possibilities for cancer treatmentSalmonella enterica serovars Typhimurium and Typhi as model organisms: revealing paradigm of host-pathogen interactionsNoninvasive imaging of infection after treatment with tumor-homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRI.Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic.Salmonella as an innovative therapeutic antitumor agent.Comparison of efficacy and toxicity of traditional Chinese medicine (TCM) herbal mixture LQ and conventional chemotherapy on lung cancer metastasis and survival in mouse models.Tumor-targeting Salmonella typhimurium A1-R prevents experimental human breast cancer bone metastasis in nude mice.Trg-deficient Salmonella colonize quiescent tumor regions by exclusively penetrating or proliferating.Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targeting Salmonella typhimurium A1-RTumor-targeting Salmonella typhimurium A1-R arrests growth of breast-cancer brain metastasis.Proliferation behavior of E. coli in a three-dimensional in vitro tumor model.Efficacy against lung metastasis with a tumor-targeting mutant of Salmonella typhimurium in immunocompetent mice.Recent progress in targeting cancer.Intraperitoneal administration of tumor-targeting Salmonella typhimurium A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice.Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse modelComparison of the selective targeting efficacy of Salmonella typhimurium A1-R and VNP20009 on the Lewis lung carcinoma in nude mice.Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model.Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapySalmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β.FSOCA-induced switchable footpad skin optical clearing window for blood flow and cell imaging in vivo.Tumor-targeting Salmonella typhimurium A1-R inhibits human prostate cancer experimental bone metastasis in mouse models.Therapeutic efficacy of tumor-targeting Salmonella typhimurium A1-R on human colorectal cancer liver metastasis in orthotopic nude-mouse modelsAdjuvant treatment with tumor-targeting Salmonella typhimurium A1-R reduces recurrence and increases survival after liver metastasis resection in an orthotopic nude mouse model.Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model.Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging.High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model.Solid tumors provide niche-specific conditions that lead to preferential growth of Salmonella.Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment.Plasmid-based E6-specific siRNA and co-expression of wild-type p53 suppresses the growth of cervical cancer in vitro and in vivo.Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model.High-efficacy targeting of colon-cancer liver metastasis with Salmonella typhimurium A1-R via intra-portal-vein injection in orthotopic nude-mouse models.The preclinical discovery of bacterial therapy for the treatment of metastatic cancer with unique advantages.Methods for the development of tumor-targeting bacteria.Treating cancer with infection: a review on bacterial cancer therapy.Antimelanoma effect of Salmonella Typhimurium integration host factor mutant in murine model.Salmonella enhance chemosensitivity in tumor through connexin 43 upregulation.Tracking of mouse breast cancer stem-like cells with Salmonella.Bugging tumors.Toxicology and efficacy of tumor-targeting Salmonella typhimurium A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice.Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma.
P2860
Q26774238-8B608473-67CA-4440-B454-DF48E5E08A82Q26996526-CFBCBD8C-5D05-4B7C-BBE7-CE78A952180FQ30677182-181F85A0-7783-46B3-B343-8D4DB5FDC17BQ34090650-02A9E13A-410D-4029-B5F0-A6E32893EAABQ34158653-2713917D-9F75-4C1A-9AEC-24E326EF7917Q34294522-DAD668AD-8FA6-48C1-8CDE-23B0EEB9469FQ34334522-D3AA7141-5AAB-4DE2-8153-12F026FD09FAQ35020097-AA06F8BD-705E-4AA4-8D72-E2D798076100Q35149573-2C559C9C-81F9-4CEF-A91E-D8B69108B118Q35550049-C9DA1219-F881-488C-8D85-73CA40F3BDADQ35708412-E1D9896C-33B4-4DDB-8F7C-C50EC128B39FQ35737450-1C63451A-73B8-4B0C-A748-A01F8514F431Q35740782-D91F0A1E-EE86-4DB3-AEF4-75AB0356BEACQ35793808-CDB1E828-44D3-4CF8-BC44-0134C426432AQ35859997-6887D3A7-EB40-45DC-882D-F58B9E0093EFQ35987427-5EF6F839-503A-4CDA-B6D0-11182DC94B3BQ36097450-73A72018-54D3-4D0F-BB1C-9F20A2EBAEF5Q36189385-BA24D57B-9ACB-4458-9D58-AD61D11948F5Q36191597-1B9D2ECC-3155-4B9B-A91E-435E8001FF7FQ36374614-40BD9E4C-2010-4A61-8152-94C5ECC2202CQ36544572-9EB6D823-BA26-4D78-BC97-7C2D4D534031Q36544581-D39570FF-1A2F-4AE5-AD5D-9BEFAC8FA0A2Q36561606-22CA08B8-82DD-4349-82A5-4ED96E3215EAQ37022286-46EFCC90-2980-428A-B533-571928A17B47Q37118741-72992C8B-A64E-40CE-9149-5A5729C94920Q37362834-E98AB67D-A5F2-45E1-8003-BFE774F3CD40Q37376492-4B072F58-206F-45E8-BC70-9D2F0DD935F0Q37416954-D30D549C-F352-4D74-B205-186794583B66Q37478104-32F1FDA9-01F3-4DFE-9191-CD07BBD4304DQ37699156-A9105B5A-47B9-4EE7-98F1-A44EB30A58B6Q37745932-A98F03D0-2BA6-4AE1-89A0-C66DCB778950Q37999090-BC931C5D-49EE-474E-9533-135B7A074247Q38221907-E400A86E-30C8-4E5B-B480-6BD6EEAE17BEQ38473938-9E01753C-66CE-4A15-9F4D-9F70424F89EEQ38850160-BF96E4FE-09A2-487F-AB45-6EBB42F12702Q39171040-A1A5CA00-41D9-470C-9EF7-07B6FDC8FFA4Q39263845-2AE0E868-2D8C-4992-82A4-A55FD26EFE86Q39587620-F861419B-DEAC-4CA9-87B9-2A0AA71CB3EFQ41551244-6DD9FCE5-632B-4191-BCBB-923A947477B1Q41661119-37CAD175-3719-4C78-B440-77E78975C793
P2860
Vessel destruction by tumor-targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularity.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vessel destruction by tumor-ta ...... ced by high tumor vascularity.
@ast
Vessel destruction by tumor-ta ...... ced by high tumor vascularity.
@en
Vessel destruction by tumor-ta ...... ced by high tumor vascularity.
@nl
type
label
Vessel destruction by tumor-ta ...... ced by high tumor vascularity.
@ast
Vessel destruction by tumor-ta ...... ced by high tumor vascularity.
@en
Vessel destruction by tumor-ta ...... ced by high tumor vascularity.
@nl
prefLabel
Vessel destruction by tumor-ta ...... ced by high tumor vascularity.
@ast
Vessel destruction by tumor-ta ...... ced by high tumor vascularity.
@en
Vessel destruction by tumor-ta ...... ced by high tumor vascularity.
@nl
P2093
P2860
P356
P1433
P1476
Vessel destruction by tumor-ta ...... ced by high tumor vascularity.
@en
P2093
Robert M Hoffman
P2860
P304
P356
10.4161/CC.9.22.13744
P577
2010-11-01T00:00:00Z